We developed a detailed protocol for technology that detects Mycobacterium avium paratuberculosis (MAP) in blood derivatives samples from human by culture and PCR. The technology has potential to be used for screening blood samples from millions of patients with inflammatory and non-inflammatory bowel diseases for MAP.
Application Serial Number
Assignee at Issuance
Burnett School of Biomedical Sciences
Biomolecular Science Center
Assignee at Filing
Nonprovisional Application Record
Naser, Saleh, "Protocol for detection of mycobacterium paratuberculosis in crohn's disease patients" (2009). UCF Patents. 484.